Article Text

PDF
New autoantigens in rheumatoid arthritis (RA): screening 8268 protein arrays with sera from patients with RA
  1. I Auger,
  2. N Balandraud,
  3. J Rak,
  4. N Lambert,
  5. M Martin,
  6. J Roudier
  1. INSERM UMR 639, Parc Scientifique de Luminy, APHM La Conception, Marseille, France
  1. I Auger, INSERM UMR 639, Parc Scientifique de Luminy, 163 avenue de Luminy, Case 939, 13009 Marseille, France; isabelle.auger{at}medecine.univ-mrs.fr

Abstract

Objective: To identify new IgG autoantibodies in sera from patients with rheumatoid arthritis (RA).

Methods: We tested serum samples from 19 patients with RA with given human leukocyte antigen (HLA)-DR genotypes, from 7 patients with spondylarthropathy, 2 patients with lupus, 4 patients with systemic sclerosis and 10 healthy individuals on 8268 human protein arrays.

Results: We identified four antigens (peptidyl arginine deiminase 4 (PAD4), protein kinase Cβ1 (PKCβ1), phosphatylinositol 4 phosphate 5 kinase type II γ (PIP4K2C) and v raf murine sarcoma viral oncogene homologue B1 catalytic domain (BRAF)) that were recognised almost uniquely by sera from patients with RA on protein arrays. Using purified proteins, we confirmed that PAD4 and BRAF are recognised almost uniquely by patients with RA.

Conclusion: We identified PAD4 and BRAF as RA specific autoantigens.

Statistics from Altmetric.com

Footnotes

  • Competing interests: None declared.

  • Funding: This work was supported by grants from INSERM, Arthritis Fondation Courtin and Société Française de Rhumatologie.

  • Ethics approval: Ethics approval was obtained from the Ethics Committee, Marseille, France.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.